Chronic Fatigue Syndrome Does Not Improve With Rituximab Chronic Fatigue Syndrome Does Not Improve With Rituximab

Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) do not improve following B-lymphocyte depletion with rituximab, according to results from the RituxME randomized controlled trial.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Internal Medicine News Source Type: news